The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells
Descrição
Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives
IJMS, Free Full-Text
A highly efficient transgene knock-in technology in clinically relevant cell types
TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components: Molecular Therapy - Nucleic Acids
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges - ScienceDirect
Advances in CRISPR therapeutics
Development of CRISPR-Cas systems for genome editing and beyond, Quarterly Reviews of Biophysics
Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
AsCas12a Ultra enables efficient one-step generation of engineered T
Intelligent nanotherapeutic strategies for the delivery of CRISPR system - ScienceDirect
The CRISPR-Cas12a Platform for Accurate Genome Editing, Gene Disruption, and Efficient Transgene Integration in Human Immune Cells
Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes
de
por adulto (o preço varia de acordo com o tamanho do grupo)
